ArticleMedicina (Kaunas, Lithuania)2025
Correction: Kalkan et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study.
Ziya Kalkan, Senar Ebinc, Murat Arcagok, Ahmet Bilici, Ozcan Yildiz, Saadettin Kilickap, Deniz Can Guven, Ali Murat Tatli, Ahmet Taner Sumbul, Nil Molinas Mandel and 4 more
Abstract readPublished Erratum
In one paragraphArticle in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
14 authors.
Ziya KalkanDepartment of Medical Oncology, Mardin Training and Research Hospital, Mardin 47100, Türkiye.ORCID 0000-0001-7858-8180 Senar EbincDepartment of Medical Oncology, Van Yuzuncu Yil University Faculty of Medicine, Van 65100, Türkiye.
Murat ArcagokDepartment of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakir 21100, Türkiye.ORCID 0000-0002-4058-6929 Ahmet BiliciDepartment of Medical Oncology, Faculty of Medicine, Medipol University, Istanbul 34000, Türkiye.ORCID 0000-0002-0443-6966 Ozcan YildizDepartment of Medical Oncology, Faculty of Medicine, Medipol University, Istanbul 34000, Türkiye.
Saadettin KilickapDepartment of Medical Oncology, Istinye University Faculty of Medicine, Istanbul 34000, Türkiye.
Deniz Can GuvenDepartment of Medical Oncology, Hacettepe University Cancer Institute, Ankara 06000, Türkiye.ORCID 0000-0002-6924-9467 Ali Murat TatliDepartment of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya 07000, Türkiye.
Ahmet Taner SumbulDepartment of Medical Oncology, Baskent University Adana Dr. Turgut Noyan Application and Research Center, Adana 01100, Türkiye.
Akin OzturkDepartment of Medical Oncology, Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul 34000, Türkiye.
Murat BardakciDepartment of Medical Oncology, Gazi Yasargil Training and Research Hospital, Diyarbakir 21100, Türkiye.ORCID 0000-0001-7854-097X Serdar KarakayaDepartment of Medical Oncology, Ankara Ataturk Sanatoryum Training and Research Hospital, Ankara 06000, Türkiye.ORCID 0000-0002-2111-7131 Muhammet Ali KaplanDepartment of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakir 21100, Türkiye.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
In the original publication, there was a mistake in Figure 2 as published [...].
Identifiers
PMID41303909
PMCPMC12654801
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390